Economy

Stock In Spotlight: Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Currently, the analyst consensus on Teva Pharma is Hold and the average price target is $19.04, representing a 67.0% upside.

Wall Street analysts are predicting that Teva Pharmaceutical Industries Ltd (NYSE:TEVA) will report earnings per share of $1.04 in their quarterly report.

Consequently Teva Pharmaceutical Industries Ltd (NYSE:TEVA)'s weekly and monthly volatility is 6.49%, 4.08% respectively. Teva Pharmaceutical Industries Limited presently has a consensus rating of Hold and a consensus target price of $26.70. Finally, Royal Bank Of Canada restated an underperform rating and set a $13.00 price objective (down previously from $15.00) on shares of Teva Pharmaceutical Industries Limited in a report on Monday. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell.

In a report issued on October 19, Cantor Fitzgerald also assigned a Hold rating to the stock with a $17 price target.

Currently, Teva Pharmaceutical Industries Limited (NYSE:TEVA) has an average volume of 27.94 Million.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) reported its EPS in the last quarter as $1.02/Share lagging the analyst estimate of $1.06/Share by a difference of $-0.04. The company issued revenue guidance of $5.3-5.4 billion, compared to the consensus revenue estimate of $5.68 billion. Teva Pharmaceutical Industries Limited had a negative net margin of 25.18% and a positive return on equity of 15.96%. The company's previous year sales total was 5.56 Million. During the same period a year ago, the company posted $1.25 earnings per share.

ILLEGAL ACTIVITY NOTICE: This piece was originally published by BBNS and is owned by of BBNS. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & worldwide copyright and trademark laws.

While looking at the Stock's Performance, Teva Pharmaceutical Industries Limited now shows a Weekly Performance of -17.97%, where Monthly Performance is -30.16%, Quarterly performance is -45.49%, 6 Months performance is -63.94% and yearly performance percentage is -74.08%. Shareholders of record on Tuesday, November 28th will be paid a dividend of $0.085 per share.

TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals.

Several brokerages have commented on TEVA. The firm's quarterly revenue was up 12.9% compared to the same quarter last year. sell-side analysts expect that Teva Pharmaceutical Industries Limited will post 4.11 EPS for the current fiscal year. Finally, BidaskClub lowered Teva Pharmaceutical Industries Limited from a sell rating to a strong sell rating in a report on Friday, October 13th. Teachers Advisors LLC now owns 642,314 shares of the company's stock valued at $20,612,000 after purchasing an additional 36,900 shares during the period. Bronfman E.L. Rothschild L.P. increased its holdings in shares of Teva Pharmaceutical Industries Limited by 2.6% in the 2nd quarter. The company was reinitiated on Monday, August 3 by JP Morgan. Penserra Capital Management LLC purchased a new position in shares of Teva Pharmaceutical Industries Limited in the 3rd quarter valued at $129,000. Bank of Nova Scotia acquired a new stake in Teva Pharmaceutical Industries Limited during the 1st quarter valued at $391,000. Institutional investors and hedge funds own 56.55% of the company's stock. Through its automobile contract purchases, the Company provides indirect financing to the clients of dealers having limited credit histories, low incomes or past credit problems, who it refers to as sub-prime customers.



Like this

loading...
loading...

Latest


04 November 2017
Shares now down at $192.02 (TMO) Thermo Fisher Scientific Reports Third…
It turned negative, as 43 investors sold TMO shares while 415 reduced holdings. 99 funds opened positions while 316 raised stakes. It also reduced Comcast Corporation Class A (NASDAQ:CMCSA) stake by 286,297 shares and now owns 3.92 million shares.

04 November 2017
Hormel Foods Corporation (HRL) stock moves -1.79% downswing with Monthly check
They hope that the stock price will fall or that the company will fail and go bankrupt, leading the equity holders to ruin. Cubist Systematic Strategies Limited Liability Corporation stated it has 2,828 shares or 0.01% of all its holdings.

04 November 2017
Monitor Lizard Found in Southern California Backyard
If the lizard was not claimed in the next few months, it will be transferred to an exotic animal sanctuary, he said. The lost 4-year-old male crocodile monitor named Chopper was returned to owner DeWitt Vercher on Friday.

04 November 2017
'Ease of doing business leads to ease of life': Modi
In Starting a Business, India has reduced the time needed to register a new business to 30 days now, from 127 days 15 years ago. Prime Minister Narendra Modi also in the same event stated that World Bank ease of doing business rank did not include GST.

04 November 2017
Cooper Tire & Rubber Company (CTB) Earns Hold Rating from Jefferies Group LLC
FNY Partners Fund LP purchased a new position in Cooper Tire & Rubber in the first quarter valued at about $110,000. The Return on Invested Capital (aka ROIC) Score for The Goodyear Tire & Rubber Company (NasdaqGS:GT) is 5.220817.

04 November 2017
Treat Him Right: Kristaps Porzingis' Brother Puts Knicks On Notice
When Porzingis blew off the exit interview, sources at the time said it was over frustration about the direction of the franchise. Knicks forward Kristaps Porzingis looks on during a game against the Rockets at Madison Square Garden on Wednesday, Nov. 1, 2017.

04 November 2017
How will the interest rate rise affect my mortgage and savings?
Surely it contributes to that very thing? He was advised to "lock-in" the record-low rate with a fixed product over the summer. Banks have no obligation to pass on rate changes to their SVR (standard variable rate), but they invariably will.

04 November 2017
Celtics look to extend win streak Friday vs. Thunder
Then, on the next possession, Irving dished to the big man for a mid-range jumper to swell the lead to six. Gordon Hayward's injury certainly didn't help.

04 November 2017
Mets pick up $8.5 million option on IF Asdrubal Cabrera
Jon Heyman of FanRag Sports reports that the Mets will pick up Asdrubal Cabrera's $8.25 million option for 2018. He later backed off the trade request, then acquiesced to playing second and third base.

04 November 2017
After Mueller charges unsealed, senator has 'serious concerns' about Sam Clovis nomination
Department of Agriculture, testified last week before a grand jury in Washington, D.C., NBC News first reported Tuesday evening. Clovis would have had no authority to prohibit such travel".